Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
VXc-522 by Vertex Pharmaceuticals for Cystic Fibrosis: Likelihood of Approval
VXc-522 is under clinical development by Vertex Pharmaceuticals and currently in Phase II for Cystic Fibrosis. According to GlobalData, Phase...